Stock 605033 SHAANXI MEIBANG PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Equities

605033

CNE100005071

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-07-14 pm EDT 		5-day change 1st Jan Change
11.76 CNY -3.13% Intraday chart for Shaanxi Meibang Pharmaceutical Group Co., Ltd. +0.86% -34.48%
Apr. 29 Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Meibang Pharmaceutical Earmarks 1.4 Billion Yuan for Factory Construction
MT
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shaanxi Yatai Testing and Evaluation Co., Ltd. announced that it has received CNY 25 million in funding from Shaanxi Meibang Pharmaceutical Group Co., Ltd.
CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shaanxi Yatai Testing and Evaluation Co., Ltd. announced that it expects to receive CNY 25 million in funding from Shaanxi Meibang Pharmaceutical Group Co., Ltd.
CI
Shaanxi Meibang Pharma Unit Buys 35.3 Million Yuan Land For Pesticide and Fertilizer Plant
MT
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd.(SHSE:605033) added to Shanghai Stock Exchange Composite Index
CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd.(SHSE:605033) added to Shanghai Stock Exchange A Share Index
CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. has completed an IPO in the amount of CNY 428.922 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 605033 Stock
  4. News Shaanxi Meibang Pharmaceutical Group Co., Ltd.